Rechercher | PaySocial | Monétisez vos compétences

partage un lien

2025-10-08 11:34:43 - Traduire -

Peli BioThermal, a global leader in temperature-controlled logistics, has acquired Evo from BioLife Solutions, strengthening its portfolio of products, services, and technology across the pharmaceutical value chain.

#PeliBioThermal #Evo #BioLifeSolutions #temperaturecontrolledlogistics #coldchainsolutions #pharmaceutical

Peli BioThermal, a global leader in temperature-controlled logistics, has acquired Evo from BioLife Solutions, strengthening its portfolio of products, services, and technology across the pharmaceutical value chain. #PeliBioThermal #Evo #BioLifeSolutions #temperaturecontrolledlogistics #coldchainsolutions #pharmaceutical

WWW.STATTIMES.COM

Peli BioThermal acquires Evo to expand cold chain solutions

Peli BioThermal adds Evo’s cryogenic shippers and evoIS platform, enhancing services for Cell and Gene Therapy markets.

0 Commentaires 0 Partages 585 Vues 0 Avis

partage un lien

2025-10-08 11:18:41 - Traduire -

Peli BioThermal, a global leader in temperature-controlled logistics, has acquired Evo from BioLife Solutions, strengthening its portfolio across the pharmaceutical supply chain. The deal expands Peli BioThermal’s offerings in cryogenic shipping and the evoIS technology platform, particularly targeting the growing Cell and Gene Therapy sector.

#PeliBioThermal #BioLifeSolutions #pharmaceuticals #coldchain #Evo #logistics

Peli BioThermal, a global leader in temperature-controlled logistics, has acquired Evo from BioLife Solutions, strengthening its portfolio across the pharmaceutical supply chain. The deal expands Peli BioThermal’s offerings in cryogenic shipping and the evoIS technology platform, particularly targeting the growing Cell and Gene Therapy sector. #PeliBioThermal #BioLifeSolutions #pharmaceuticals #coldchain #Evo #logistics

WWW.ITLN.IN

Peli BioThermal expands cold chain solutions with acquisition of Evo

Peli BioThermal acquires Evo, boosting cold chain solutions for pharmaceuticals and Cell & Gene Therapy markets.

0 Commentaires 0 Partages 312 Vues 0 Avis